Scholarlink

<p>Enhanced Recovery After Surgery (ERAS) protocols have become a comprehensive approach to perioperative care, emphasizing multimodal interventions to reduce surgical stress, enhance postoperative recovery, and minimize complications. While ERAS protocols have demonstrated success in various surgical specialties, their application in oral cancer reconstruction remains relatively under-researched. To explore the ERAS measures’ impact on oral squamous cell carcinoma (OSCC) reconstruction patients’ prognosis and comparison to traditional methods. OSCC patients undergoing reconstruction surgery were randomly assigned to control (traditional management) or experimental (ERAS measures) groups. The general data, serum nutritional indicators (albumin, transferrin, prealbumin, hemoglobin), serum inflammatory indicators (interleukin-6, C-reactive protein, tumor necrosis factor α, white blood cell count), recovery indicators (first out-of-bed time after surgery, infusion time after surgery, length of hospital stay, anxiety score), quality of life indicators (material life, psychological function, social function, physical function), postoperative pain, flap survival rate, and postoperative complication rate at 1&#xa0;day before surgery and 14&#xa0;days after surgery were assessed and compared between the two groups. A total of 62 patients were included, with 31 patients in each group. In a study involving 62 OSCC reconstruction patients, those under Enhanced Recovery After Surgery (ERAS) measures exhibited higher postoperative nutrition levels (albumin, transferrin, prealbumin, and hemoglobin) (all <i>P</i> &lt; 0.001) and lower inflammatory markers interleukin-6, C-reactive protein, and tumor necrosis factor α (all <i>P</i> &lt; 0.01). They experienced shorter times for first out-of-bed, infusion, and hospitalization after surgery (<i>P</i> &lt; 0.001), less anxiety (<i>P</i> &lt; 0.001), lower postoperative pain (<i>P</i> &lt; 0.001), improved quality of life (<i>P</i> &lt; 0.001), and fewer complications compared to the control group (35.48% vs. 93.55%, <i>P</i> &lt; 0.001). ERAS perioperative management significantly improved prognosis, recovery, and quality of life for OSCC reconstruction patients compared to traditional methods.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Accelerated Rehabilitation Surgery in the Perioperative Management of Patients with Oral Cancer Reconstruction

  • 期刊论文

  • 发表日期：

    2025年6月19日

查看全文
  • Lang Cheng,
  • Chengtao Wang,
  • Lei Wang,
  • Yuxin Xie,
  • Dan Zhao,
  • Shuangjiang Wu

摘要

Enhanced Recovery After Surgery (ERAS) protocols have become a comprehensive approach to perioperative care, emphasizing multimodal interventions to reduce surgical stress, enhance postoperative recovery, and minimize complications. While ERAS protocols have demonstrated success in various surgical specialties, their application in oral cancer reconstruction remains relatively under-researched. To explore the ERAS measures’ impact on oral squamous cell carcinoma (OSCC) reconstruction patients’ prognosis and comparison to traditional methods. OSCC patients undergoing reconstruction surgery were randomly assigned to control (traditional management) or experimental (ERAS measures) groups. The general data, serum nutritional indicators (albumin, transferrin, prealbumin, hemoglobin), serum inflammatory indicators (interleukin-6, C-reactive protein, tumor necrosis factor α, white blood cell count), recovery indicators (first out-of-bed time after surgery, infusion time after surgery, length of hospital stay, anxiety score), quality of life indicators (material life, psychological function, social function, physical function), postoperative pain, flap survival rate, and postoperative complication rate at 1 day before surgery and 14 days after surgery were assessed and compared between the two groups. A total of 62 patients were included, with 31 patients in each group. In a study involving 62 OSCC reconstruction patients, those under Enhanced Recovery After Surgery (ERAS) measures exhibited higher postoperative nutrition levels (albumin, transferrin, prealbumin, and hemoglobin) (all P < 0.001) and lower inflammatory markers interleukin-6, C-reactive protein, and tumor necrosis factor α (all P < 0.01). They experienced shorter times for first out-of-bed, infusion, and hospitalization after surgery (P < 0.001), less anxiety (P < 0.001), lower postoperative pain (P < 0.001), improved quality of life (P < 0.001), and fewer complications compared to the control group (35.48% vs. 93.55%, P < 0.001). ERAS perioperative management significantly improved prognosis, recovery, and quality of life for OSCC reconstruction patients compared to traditional methods.